The aim of this study was to investigate the changes in hepatic oxidative phosphorylation (OXPHOS) complexes (COs) in patients and cows with non-alcoholic steatohepatitis (NASH) and to investigate the mechanism that links mitochondrial dysfunction and hepatic insulin resistance induced by non-esterified fatty acids (NEFAs). Patients and cows with NASH displayed high blood NEFAs, TNF-a and IL-6 concentrations, mitochondrial dysfunction and insulin resistance. The protein levels of peroxisome proliferator-activated receptor-c coactivator-1a (PGC-1a), mitofusin-2 (Mfn-2) and OXPHOS complexes (human: COI and COIII; cow: COI-IV) were significantly decreased in patients and cows with NASH. NEFA treatment significantly impaired mitochondrial function and, increased reactive oxygen species (ROS) production, and excessive ROS overactivated the JNK and p38MAPK pathways and induced insulin resistance in cow hepatocytes. PGC-1a and Mfn-2 overexpression significantly decreased the NEFAinduced ROS production and TNF-a and IL-6 mRNA expressions, reversed the inhibitory effect of NEFAs on mitochondrial function and attenuated the overactivation of the ROS-JNK/p38MAPK pathway, alleviated insulin resistance induced by NEFAs in cow hepatocytes and HepG2 cells. These findings indicate that NEFAs induce mitochondrial dysfunction and insulin resistance mediated by the ROS-JNK/p38MAPK pathway. PGC-1a or Mfn-2 overexpression reversed the lipotoxicity of NEFAs on mitochondrial dysfunction and insulin resistance. Our study clarified the mechanism that links hepatic mitochondrial dysfunction and insulin resistance in NASH.
accumulation. [3] [4] [5] [6] A high NEFA level is the pathological basis of fatty liver; however, the detailed molecular mechanisms underlying this pathology are not clearly understood.
The regulation of hepatic lipid metabolism is largely dependent on mitochondria, the primary organelle of cellular adenosine triphosphate (ATP) production, using the energy released from the respiratory chain mediated by OXPHOS complexes (COI, COII, COIII, COIV and COV). 7 NEFAs are a crucial energy source in the liver and peripheral tissues.
However, high level of NEFAs caused lipotoxicity and could impair hepatic mitochondrial function and insulin signalling. 8, 9 Furthermore, studies in humans and experimental models have shown that mitochondrial dysfunction is involved in the development of insulin resistance and NAFLD. 10, 11 A study in rats showed that impairment of the mitochondrial respiratory chain results in mitochondrial ROS overproduction, which in turn causes oxidative damage to mitochondrial structure and function, leading to abnormal changes in intracellular signalling and the development of insulin resistance. 12, 13 The regulation and maintenance of mitochondrial function require regulators, such as peroxisome proliferator-activated receptor-c coactivator-1a
(PGC-1a) and mitofusin-2 (Mfn-2), which play critical roles in regulating mitochondria biogenesis, respiration and OXPHOS. 14 Besides, studies had shown that adipose PGC-1a deficiency clearly leaded to systemic deregulation of glucose homoeostasis, and obesity induced by a high-fat diet (HFD) reduced Mfn-2 expression in muscle. 15, 16 However, the effects of PGC-1a and Mfn-2 on insulin signalling in hepatocytes are still not well understood.
Results from ob/ob mice, mice fed a HFD, patients with NAFLD or type 2 diabetes and L6 skeletal muscle cells have demonstrated that insulin resistance might coexist with mitochondrial alterations such as lower mitochondrial density, OXPHOS gene expression and ATP synthesis. 10, [17] [18] [19] [20] However, these previous studies investigated the mitochondrial dysfunction and insulin resistance in NAFLD and type 2 diabetes mainly using skeletal muscle and rarely using liver tissue, especially in patients with NASH. Recently, a study reported that the adaptation of hepatic mitochondrial function in humans with insulin resistance is lost in NASH, 21 although the underlying mechanism remains unclear. High level of NEFAs caused lipotoxicity and impaired fatty acid oxidation in mitochondria affects mitochondrial function, contributes to fat accumulation and hepatic steatosis and correlates with impaired insulin signalling. Therefore, it is of great interest to clarify the relevant mechanisms that link high level of NEFAs, mitochondrial dysfunction and hepatic insulin resistance in humans or dairy cows with NASH. Furthermore, the changes in the expression of hepatic mitochondrial OXPHOS complexes in humans and cows with NASH are poorly characterized. Table S1 .
| MATERIALS AND METHODS

| Human liver specimens
| Animals
All animal experiments were carried out in accordance with the rec- Table S2 .
During the experimental work, the cows were housed in a climatecontrolled barn in individual tie stalls to reduce environmental effects.
| Hepatocyte culture and treatment
All animal experiments were carried out in accordance with the rec- and detailed grouping were shown in the figure legends.
| Serum malondialdehyde and superoxide dismutase measurements
The content of malondialdehyde (MDA) and activity of superoxide dismutase (SOD) were measured using biochemical kits (Nanjing Jiancheng Institute of Bioengineering, Nanjing, China). The MDA measurement was based on the reaction with thiobarbituric acid in acidic medium at 95°C at 533 nm. The MDA concentration was calculated from the standard curve and expressed as nmol/mL serum. SOD activity was determined spectrophotometrically at 550 nm by use of xanthine and xanthine oxidase systems. One unit of SOD activity was defined as the amount of enzyme required to cause 50% inhibition of the xanthine and xanthine oxidase system reaction of 1 mg haemoglobin. SOD activity was expressed as U/mg of haemoglobin. 
| Western blotting assay
| Determination of ATP concentration, membrane potential and ROS concentration
The ATP concentration of hepatocytes was measured using an ATP assay kit (Beyotime Institute of Biotechnology, Shanghai, China) following the manufacturer's protocol. Briefly, the cells were lysed in lysis buffer and centrifuged at 4°C and 12 000 g for 10 minutes.
The supernatants were used for ATP detection using a Centro 
| Histological analysis
Liver tissue haematoxylin and eosin (HE) staining was conducted after the tissue was fixed in methanol-free 4% paraformaldehyde for 24-36 hours. For HE staining, the paraffin-embedded specimens were sectioned at 5 lm and then stained. The ultrastructural characteristics of mitochondria in treated and control cells were visualized by transmission electron microscopy. Liver tissue and cow hepatocytes were fixed, dehydrated and infiltrated. Ultrathin sections (50 nm) were cut and stained with 4% uranyl acetate and 0.2% lead citrate. Finally, the sections were examined with an H-7650 electron microscope.
| Detection of blood biochemical indicators
Glucose 
| Measurement of liver TG contents
Approximately 30 mg of liver tissue was chopped and homogenized in 0.5 mL of 5% Triton-X100 in water. The homogenized tissue was heated in a water bath (85°C) for 3 minutes. After cooling at room temperature, the samples were vortexed and centrifuged at 2000 g for 5 minutes at 4°C. The supernatant was collected and stored at À80°C before the TG assay. The TG contents were measured using an enzymatic kit (Applygen Technologies Inc., Beijing, China) following the manufacturer's instructions.
| Statistical analysis
The results are expressed as the means AE standard deviation (SD).
SPSS software (SPSS Incorporated, Chicago, IL, USA) version 19.0 was used to analyse the data. Statistical significance was calculated using Student's t test in cases of comparisons between two groups and one-way ANOVA in cases of comparisons among more than two groups. A P value less than .05 was considered statistically significant, and values less than 0.01 were considered highly significant.
3 | RESULTS
| The evaluation of hepatic insulin signalling in patients and cows with NASH
The baseline characteristics of control and NASH subjects are shown in Table S1 . The blood levels of fasting free fatty acids, glucose, TGs, insulin and HbA1 c and the HOMA-IR and BMI of patients with NASH were significantly higher than those of controls. The hepatic phosphorylation level of AKT (p-AKT/AKT, at Ser473) was significantly lower in patients with NASH than in controls ( Figure 1A and B). Furthermore, the blood concentration of IL-6, TNF-a, ALT, AST and c-GT was also significantly increased in patients with NASH (Table S1 ). Besides, the ratio of AST/ALT was significantly increased in the serum of patients with NASH (Table S1 ). Moreover, HE staining showed that patients with NASH exhibited significant lipid accumulation and inflammatory infiltration ( Figure 1C ). The hepatic TG content in patients with NASH was also significantly higher than that of controls ( Figure 1D ). These results indicate that patients with NASH have clear systemic and liver insulin resistance, inflammation, lipid accumulation and hepatic injury.
Similar to NASH patients, HE staining of liver tissue from cows with NASH showed significant lipid accumulation and inflammatory infiltration ( Figure 1E ). Dairy cows with NASH also displayed high blood concentrations of NEFAs, TNF-a, IL-6, ALT, AST and c-GT (Table S2 ) and hepatic TG accumulation ( Figure 1F ). Moreover, the phosphorylation levels of IRS2 (p-IRS2/IRS2, at Ser731), AKT (at Ser473) and GSK3b (p-GSK3b/GSK3b, at Ser9) were significantly decreased in cows with NASH ( Figure 1G and H). These results indicate that cows with NASH also exhibit systemic and liver insulin resistance, inflammation, lipid accumulation and hepatic injury.
| Patients and cows with NASH display mitochondrial dysfunction
The mitochondrial function regulators PGC-1a, Mfn-2, NRF1 and TFAM play critical roles in regulating mitochondria biogenesis, respiration and OXPHOS. [25] [26] [27] Our in vivo data showed that the protein levels of PGC-1a, Mfn-2, NRF-1 and TFAM were significantly decreased in patients and cows with NASH (Figure 2A-D) . Furthermore, we found that the protein levels of COI-V were lower in patients with NASH than in controls, and COI and COIII were significantly decreased (Figure 2A ,B). These results indicate that patients with NASH display defects in the hepatic mitochondrial respiratory chain. In addition, the protein expression of COI-IV was significantly lower in cows with NASH than in the control cows ( Figure 2C,D) .
Ultrastructural analysis revealed a uniform accumulation of cytosolic lipid droplets in the hepatocytes of cows with NASH, indicative of microvesicular steatosis. In addition, the mitochondria displayed swollen and crest ruptures ( Figure 2E ). These results further indicate that patients or cows with NASH display severe mitochondrial dysfunction.
| High NEFAs cause mitochondrial dysfunction and insulin resistance in cow hepatocytes in vitro
Excessive NEFA flux into the liver is the pathological basis of fatty liver, inducing a series of pathological changes, such as oxidative stress, inflammation, hepatic steatosis and insulin resistance. 3, 28, 29 We therefore attempted to investigate the relevant mechanisms that link NEFAs, mitochondrial dysfunction and hepatic insulin resistance in vitro via cow hepatocytes. All data are expressed as mean AE SD. *P < .05 and **P < .01 compared with normal liver group. Subjects: eight patients with NASH and six healthy subjects. Animals: twenty healthy Holstein cows and ten cows with NASH. Each treatment was repeated 8 times. PGC-1a, peroxisome proliferator-activated receptor-c coactivator-1a; Mfn-2, mitofusin-2; NRF1, nuclear respiratory factor 1; TFAM, mitochondrial transcription factor A; TEM, transmission electron microscope
| 3413 cow hepatocytes ( Figure 4F-I ). Alpha-lipoic acid (ALA) is an antioxidant that acts on mitochondria. 33 We found that ALA treatment could decrease the phosphorylation levels of JNK and p38MAPK 
| PGC-1a overexpression improves mitochondrial dysfunction and insulin resistance induced by NEFAs in cow hepatocytes
PGC-1a plays a critical role in regulating mitochondria function. 34 To determine the role of PGC-1a in the mitochondrial dysfunction and insulin resistance induced by NEFAs, PGC-1a was overexpressed by adenovirus ( Figure S2 ). As shown in Figure 5A , PGC-1a overexpression significantly reversed the inhibitory effect of NEFAs on the protein expression of COI, COII, COIII, COIV and COV ( Figure 5A ,B), increased ATP production ( Figure 5C ) and increased membrane potential ( Figures 5D and S3A) . 
| DISCUSSION
Fatty liver is a major metabolic disorder in humans and perinatal dairy cows. Studies have focused on the molecular pathogenesis of NASH in humans mainly using rodent models. Compared with rodent models, dairy cows with NASH have advantages in studies of the molecular pathogenesis of NASH. First, cows are one of the few animals that exhibit naturally occurring fatty liver. Second, patients and cows with NASH both display high NEFA levels, hepatic steatosis, hepatic insulin resistance, oxidative stress and inflammation. In a study by Straub et al, cow and human liver samples were used to investigate the mechanism of hepatic steatosis. 35 We therefore chose cows with NASH and cow hepatocytes as the animal and cell models to investigate the mechanism of mitochondrial dysfunction and insulin resistance. were markedly decreased in the livers of patients with NASH. 36 Koliaki et al found that the protein levels of COI, III, IV and V were lower in patients with NASH than in controls after correcting for mitochondrial content. 21 In our study, we found that the hepatic protein levels of COI-V showed a decreasing trend, and COI and III alcohol. 39 The discrepancies in the hepatic protein levels of COI-IV and the AST/ALT ratio between previous studies and our study could be due to differences in samples, the degree of hepatic pathological damage, nutritional factors or genetic factors.
Impaired mitochondrial OXPHOS complexes further decreased the mitochondrial fatty acid b-oxidation and enhanced TG accumulation.
Subsequently, hepatic fatty acid and TG overload can directly inhibit several enzymes involved in the mitochondrial respiratory chain. 26 Our results showed that NEFA treatment resulted in markedly decreased OXPHOS complexes, POLG2 and SSBP1 expression and ATP content and impaired mitochondria structure in hepatocytes. Furthermore, we also found that insulin resistance coexisted with mitochondrial dysfunction in patients and cows with NASH, and NEFA treatment impaired the insulin pathway in hepatocytes. The results of patients and cows with NASH and hepatocytes led us to speculate that defective protein expression of OXPHOS complexes may be an important factor in NEFA-induced insulin resistance.
The mitochondrial electron transport chain mediated by OXPHOS complexes is the main source of cellular ROS. 40 Defective protein expression of complexes (COI-V) could induce a "leaky" transfer of electrons to molecular oxygen during OXPHOS, thus increasing ROS generation. 41 Our study showed that patients and cows with NASH displayed severe oxidative stress. Importantly, the ROS content in the NEFA-treated hepatocytes was significantly increased, which suggested that defects in OXPHOS complexes induce ROS overgeneration. It is well known that excessive ROS directly damages DNA, proteins and lipids and indirectly activates a variety of stress-sensitive intracellular signalling pathways, such as p38MAPK and JNK, thus impairing the insulin pathway. 26, 42, 43 In our study, NEFA treatment induced the over- pathway, resulting in insulin resistance. However, ROS can be generated by mitochondria, endoplasmic reticulum stress and NADPH oxidase. 44, 45 Therefore, it will be necessary to perform additional studies to investigate the source of ROS in NEFA-treated hepatocytes. further confirming the beneficial role of PGC-1a on mitochondrial dysfunction and insulin resistance in NASH. However, as shown in Figure 5B , NEFA treatment led to a striking increase in COII in the presence of Ad-PGC-1a in hepatocytes. We speculated that NEFAinduced expression of COII in the presence of Ad-PGC-1a was a compensatory mechanism of mitochondria. Therefore, to investigate the effects of this compensatory mechanism, it will be necessary to perform additional studies.
Mfn-2 is more abundant in the heart, skeletal muscle, brain and brown adipose tissue than in the liver cells. Its function in liver cells has usually been ignored in previous studies. In our study, we found that hepatic Mfn-2 protein levels were significantly decreased in patients and cows with NASH and in NEFA-treated hepatocytes.
Importantly, Mfn-2 overexpression significantly increased COI, COIII and COIV expression and ATP production, restored the membrane potential; suppressed the ROS-JNK/p38MAPK pathway, thereby improving insulin resistance in hepatocytes. Furthermore, we also found that Mfn-2 overexpression could reverse the inhibition of data also demonstrated that cows with fatty liver may be ideal animal models for the study of human NAFLD.
